Institut Virion-Serion

Wurzburg, Germany Founded: 1978 • Age: 48 yrs Acquired By HQIB
Kits and analyzers for infectious diseases
Request Access

About Institut Virion-Serion

Institut Virion-Serion is a company based in Wurzburg (Germany) founded in 1978 by Brigitte Hermann, Judith Striker, and Gerhard Hermann was acquired by HQIB in February 2024.. Institut Virion-Serion offers products and services including SERION ELISA classic, SERION antigens, SERION antibodies, and SERION plasma. Institut Virion-Serion operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.

  • Headquarter Wurzburg, Germany
  • Founders Brigitte Hermann, Judith Striker, Gerhard Hermann
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Institut Virion\Serion Gmbh
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    HQIB

    (Feb 27, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Institut Virion-Serion

Institut Virion-Serion offers a comprehensive portfolio of products and services, including SERION ELISA classic, SERION antigens, SERION antibodies, and SERION plasma. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Immunoassays for detecting antibodies against human pathogens.

Antigens for assay development and infectious disease diagnostics.

Monoclonal antibodies for IVD calibrators and controls.

Plasma products for creating diagnostic calibrators.

Funding Insights of Institut Virion-Serion

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Institut Virion-Serion

Institut Virion-Serion has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include HQIB. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
A long-term oriented industrial holding company is managed by HQIB.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Institut Virion-Serion

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Institut Virion-Serion

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Institut Virion-Serion Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Institut Virion-Serion

Institut Virion-Serion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
domain founded_year HQ Location
Provider of machine learning based diagnostic solutions for infectious diseases
domain founded_year HQ Location
Portable PCR diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Instruments and test panels for multiplexed molecular diagnostics are provided.
domain founded_year HQ Location
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Institut Virion-Serion

Frequently Asked Questions about Institut Virion-Serion

When was Institut Virion-Serion founded?

Institut Virion-Serion was founded in 1978.

Where is Institut Virion-Serion located?

Institut Virion-Serion is headquartered in Wurzburg, Germany. It is registered at Wurzburg, Bavaria, Germany.

What does Institut Virion-Serion do?

Institut Virion-Serion is engaged in development and marketing of in-vitro diagnostic products for infectious diseases. The company offers wide range of products for the serological detection of infectious diseases including SERION ELISA classic (allows qualitative and quantitative antibody detection), SERION ELISA antigen immunoassays, SERION ELISA control, SERION Multianalyt technology (fluorescence immunoassays)- is a particle based technology that allows simultaneous quantification of multiple parameters, SERION neonatal for the detection of antibodies respiratory infections in newborns, and complement fixation test (CFT). In addition, the company offers a four-plate and a two-plate benchtop ELISA analyzers. The company offers its product through a team of sales representatives.

Who are the top competitors of Institut Virion-Serion?

Institut Virion-Serion's top competitors include Visby Medical, Inflammatix and MeMed.

What products or services does Institut Virion-Serion offer?

Institut Virion-Serion offers SERION ELISA classic, SERION antigens, SERION antibodies, and SERION plasma.

Who are Institut Virion-Serion's investors?

Institut Virion-Serion has 1 investor. Key investors include HQIB.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available